Does Adding Bevacizumab Therapy in Glaucoma Surgery Improve the Success of Needle Bleb Revisions?

Completed · Phase 2/Phase 3

Conditions studied: Glaucoma

In brief

The purpose of this study is to see if a new add on (or adjunctive) therapy used in glaucoma surgery improves the success of needle bleb revisions.

Key facts

Study ID

NCT00853073

Run by

Wills Eye

People needed

63

Starts

2009-02-01

Expected to finish

2012-01-01

Last updated by the study team

2018-07-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• require glaucoma bleb needle revision with Mitomycin-C

You may not qualify if…

• pregnant, nursing, or not using adequate contraception
• other glaucoma eye surgery involving tube shunts
• prior retinal detachments surgery with scleral buckle
• infection, inflammation, or any abnormality preventing eye pressure measurement
• enrolled in another investigational study

Where it is running

• Wills Eye Institute, Glaucoma Service — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.